相似文献
1
The dream of biologics in uveitis.
Arch Ophthalmol. 2010 May;128(5):632-5. doi: 10.1001/archophthalmol.2010.47.
2
[Monoclonal antibody therapy for uveitis].
Nihon Rinsho. 2002 Mar;60(3):556-62.
3
Immunosuppressive therapy for ocular diseases.
Curr Opin Ophthalmol. 2008 Nov;19(6):535-40. doi: 10.1097/ICU.0b013e3283126d20.
4
Uveitis treatment trials--a cross-study perspective.
Ocul Immunol Inflamm. 2012 Apr;20(2):63-7. doi: 10.3109/09273948.2012.661297. Epub 2012 Feb 23.
5
[The use of interferon alfa-2r in the treatment of autoimmune uveitis (primary or associated with Behçet's disease)].
Rev Clin Esp. 1996 May;196(5):293-8.
6
Retrospective analysis of children with uveitis treated with infliximab.
J AAPOS. 2008 Dec;12(6):611-3. doi: 10.1016/j.jaapos.2008.08.007. Epub 2008 Oct 19.
7
A systematic review of biologics for the treatment of noninfectious uveitis.
Immunotherapy. 2013 Jan;5(1):91-102. doi: 10.2217/imt.12.134.
8
Infliximab-related malignant melanoma and cranial nerves IX and XII palsy secondary to IFN-α2b therapy.
Int J Dermatol. 2013 Dec;52(12):1613-5. doi: 10.1111/j.1365-4632.2011.05452.x. Epub 2013 Feb 22.
9
Which way forward for treatment of severe ocular inflammation?
Clin Exp Ophthalmol. 2006 May-Jun;34(4):293-4. doi: 10.1111/j.1442-9071.2006.01244.x.
10
[Treatment of chronic viral hepatitis].
Ugeskr Laeger. 2008 Jun 9;170(24):2137-40.
引用本文的文献
1
Biologic agents in experimental autoimmune uveitis.
Int Ophthalmol. 2014 Feb;34(1):145-56. doi: 10.1007/s10792-013-9756-0. Epub 2013 Mar 14.
2
[Monitoring treatment with biologics in non-infectious uveitis].
Ophthalmologe. 2011 Jan;108(1):21-4. doi: 10.1007/s00347-010-2257-x.
Zotero 插件